Nasojejunal Feeding Versus Oral Feeding Following Endoscopic Drainage of Walled Off Pancreatic Necrosis
1 other identifier
interventional
50
1 country
1
Brief Summary
The goal of this randomized control trial is to assess whether nasojejunal feed is better than oral nutrition in patients who are undergoing endoscopic cystogastrostomy of walled off necrosis following acute pancreatitis. It will also try to answer, the incidence of infections and feed tolerance. The main question it tries to answer is
- 1.whether nasojejunl feed is better than oral feed in patients undergoing endoscopic cystogastrostomy in walled off necrosis following acute pancreatitis
- 2.How much infections they develop, whether they are able to tolerate the feed, weight gain and reintervention rates in each group
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 18, 2025
CompletedFirst Submitted
Initial submission to the registry
November 18, 2025
CompletedFirst Posted
Study publicly available on registry
February 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2027
February 9, 2026
January 1, 2026
1.2 years
November 18, 2025
January 31, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Nutritional failure
To compare the rate of nutritional failure at Day 14 between Nasojejunal and oral feeding post endoscopic transmural drainage of WON
14 days
Secondary Outcomes (4)
Infection and new onset organ failure
14 days
Re-intervention needs
14 days
Change in weight
14 days
Inflammatory markers
14 days
Study Arms (2)
Nasojejunal feeding arm
EXPERIMENTALOral feeding
ACTIVE COMPARATORInterventions
Nasojejunal tube will be placed post EUS-CG or oral diet would be started after randomization
Eligibility Criteria
You may qualify if:
- Patients of acute pancreatitis (AP) with 18-75 years of age
- Patients with symptomatic WON requiring EUS guided transluminal drainage
- Provision of written informed consent
You may not qualify if:
- Patients with collection not amenable for EUS guided drainage (distance of WON \>1 cm from the gastrointestinal lumen)
- Known malignancy or immunocompromised state
- Previous upper gastrointestinal(GI) surgery interfering with absorption
- Active GI bleeding
- GI obstruction, ileus or persistent vomiting
- Patients moribund to undergo endoscopic procedure (Glasgow coma scale \<8 or patients on ventilatory support)
- Patients with irreversible coagulopathy like platelets \<50,000/mm3 and/or INR\>1.5
- Pregnant or lactating female
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Post Graduate Institute of Medical Education and Research (PGIMER)
Chandigarh, 160012, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Surender Singh Rana, Professor
Post Graduate Institute of Medical Education and Research, Chandigarh
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Resident, Department of Gastroenterology
Study Record Dates
First Submitted
November 18, 2025
First Posted
February 9, 2026
Study Start
October 18, 2025
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
January 1, 2027
Last Updated
February 9, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
- Time Frame
- After 1 year
- Access Criteria
- Who wants to publish individual data meta-analysis